Valuation models
price $251.82 · as of Nov 2, 2026
DCF · Perpetuity growth · 5yused165.33 – 307.96218.8415% overvaluedDCF · Perpetuity growth · 10y189.21 – 338.24245.303% overvaluedDCF · EBITDA exit · 5y282.55 – 313.05297.3915% undervaluedDCF · EBITDA exit · 10y284.75 – 342.80312.3719% undervaluedP/E · peers218.36 – 262.31256.382% undervaluedP/E · own history159.29 – 224.30184.7936% overvaluedPEG—140.0280% overvaluedEV/EBITDA · peers266.06 – 297.24269.036% undervaluedEV/Revenue · peers224.93 – 736.33508.8351% undervaluedEarnings power value78.01 – 151.86107.03135% overvaluedDividend discount57.03 – 166.9288.51185% overvaluedWall St. consensus target—260.003% belowCost of capital (WACC)—7.01%—
DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. How the headline model is chosen.
Model value · DCF · Perpetuity growth · 5y
218.84
Quest Diagnostics closed at $251.82 — overvalued by 15% vs model.
165.33the model's range307.96
DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.
Other models
88.51 – 508.83
Wall St. target
260.00 3% below
Above model, 1y
11 of 30 days
How it is valued
Valued asMature & stable
Low/slowing growth (~9% recent)Moderate margins (9% net margin)Pays dividendsHighly cyclical earnings
Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.